Chemical Shift Encoding-based Water-fat Magnetic Resonance Imaging in Spinal Tumors

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT05631002

Enrollment

150

Registered

2022-11-30

Start date

2022-08-01

Completion date

2023-12-31

Last updated

2022-11-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bone Tumor, Spinal Tumor

Brief summary

Fat composition of the spinal tumors is positively correlated with classification and differential diagnosis of benign and malignant tumors.

Detailed description

Chemical shift encoding-based water-fat magnetic resonance imaging (MRI) is a non-invasive method that provides quantitative information about the biochemical water-fat composition of bone marrow and skeletal muscle in vivo.

Interventions

DIAGNOSTIC_TESTChemical shift encoding-based water-fat MRI

Chemical shift encoding-based water-fat magnetic resonance imaging (MRI): a non-invasive method

Study design

Observational model

CASE_CONTROL

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Healthy volunteers

Inclusion criteria

* Pathological biopsy of a patient with diagnosed spinal tumor lesion, and preoperative examination Chemical shift encoding-based water-fat MRI was performed.

Exclusion criteria

* Recurrent neoplasms; Lesion diameter \< 1 cm; Poor image quality.

Design outcomes

Primary

Measure	Time frame	Description
Type of tumor	One month before treatment	Pathological diagnosis

Countries

China

Contacts

Primary ContactQizheng Wang

wangqizheng96@163.com13161593501

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026